Steroid analysis by LC-MS/MS in daily clinical routine diagnostics requires high-throughput conditions including fast chromatographic separation. Hereby, signal interferences may occur due to limited specificity in complex biologic matrices. During the last three years of routine steroid analysis in our laboratory and roughly 50,000 measurements, about 1% was affected by interferences, mainly serum cortisol (> 90%) and dried blood 17α-hydroxyprogesterone (17-OHP). To overcome specificity problems, enhanced chromatography, ionization polarity switching, and detection via two-stage fragmentation (MS 3 ) using a quadrupole linear ion trap were investigated in our study. Signal interferences of serum cortisol were eliminated by applying a protocol for automated method switching without changing the basic high-throughput LC-MS/MS setup. This approach includes negative ionization and extended chromatography from 4 to 6.6 min using the fourfold column length. From 9 samples affected by cortisol interference using the high-throughput method, 8 could be reliably analyzed applying the method switching protocol. Moreover, the applicability of the high-throughput method as second tier analysis in congenital adrenal hyperplasia (CAH) diagnostics from dried blood was verified with 100% diagnostic specificity. In addition, the combination of fast LC and MS 3 detection enables specific quantitation of 17-OHP from dried blood spots on a screening time scale. This approach may be an alternative to the newborn screening for CAH by immunoassay due to its higher specificity, reducing the number of false positive results by 90%. In this work we recap experiences from three years of clinical routine steroid analysis via LC-MS/MS and present a unique analytical setup that enables both high-throughput and enhanced resolution analysis of steroid hormones in serum and dried blood.
Introduction
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has become an alternative for steroid analysis in clinical routine diagnostics due to simplified sample preparation and increased specificity and accuracy compared to immunoassays (IA). Furthermore, it permits simultaneous quantitation of multiple steroids opening up novel diagnostic opportunities [1] [2] [3] . Recently, we published a highthroughput method for steroid analysis and implemented it in our clinical routine laboratory [4] . This method allowed the simultaneous quantitation of 17αhydroxyprogesterone (17-OHP), aldosterone, androstenedione (AE), cortisol (F), cortisone, dehydroepiandrosterone sulfate (DHEAS), estradiol, progesterone (P), and testosterone (T) from 100 μL of human plasma/serum, saliva, and urine with a total run time of 4 min. With a daily throughput of more than 50 samples and additional clinical trials, about 50,000 samples were analyzed so far [5] [6] [7] [8] [9] . During routine analysis of serum samples analytical problems regarding specificity occurred in roughly 1% of the samples (> 90% of affected concerned cortisol). In the meantime, we expanded the method for 17-OHP analysis in dried blood for confirmation (second tier testing) of positive results in newborn screening for congenital adrenal hyperplasia (˜1% positive results from 40,000 samples per year). To improve the analytical specificity of the high-throughput LCMS/MS setup for cortisol and 17-OHP, variation of chromatography, ionization mode, and mass spectrometric scan mode appeared as viable options. By introduction of two-stage fragmentation using a quadrupole linear ion trap (MS 3 ), the specificity of mass spectrometric detection coupled to fast chromatographic separation can be further enhanced without sacrificing analysis time [4, 10, 11] . Therefore, the potential of LC-MS 3 for analyzing 17-OHP in primary newborn screening was evaluated. In this work, we investigated method optimization strategies to increase specificity for serum cortisol and dried blood 17-OHP. Furthermore, we provide a decision tree for the user to navigate the different routes of problem solving that are presented here.
Materials and methods

Chemicals and reagents
HPLC grade methanol was purchased from Biosolve (Valkenswaard, Netherlands). Deionized water was produced in-house with a Barnstead Nanopure from Thermo Scientific (Waltham, MA, USA). Zinc sulfate heptahydrate was acquired from Merck (Darmstadt, Germany), ammonium fluoride from Sigma Aldrich (St. Louis, MO, USA). MassChrom ® steroid serum calibrators and controls were purchased from Chromsystems Instruments & Chemicals GmbH (Munich, Germany). 17-OHP, androstenedione, cortisol were obtained from Sigma Aldrich (St. Louis, MO, USA). Deuterated standards 17-OHP-d8 and androstenedione-d7 were acquired from CDN Isotopes (Pointe-Claire, Quebec, Canada). Estradiol-d5, testosterone-d3, aldosterone-d7, progesteroned9, DHEAS-d6, cortisol-d4 and cortisone-d7 were purchased from Sigma Aldrich (St. Louis, MO, USA). Methanolic working standards were produced for all analytes and internal standards based on 1 mg/ mL (2.73.7 mmol/L) stock solutions.
Human samples
Anonymized residual material of serum and dried blood was taken from routine diagnostics of the University Hospital Leipzig (ethical approval 082-10-190-42010).
Sample preparation
Aliquots of 100 μL of calibrators, quality controls, blank controls, serum, plasma were treated with 200 μL precipitating agent (ZnSO 4 in water (0.3 mol/L)/methanol 1/4 v/v, including the internal standards), thoroughly mixed and centrifuged for 10 min at 14,000 × g. The supernatant was transferred to autosampler vials with 250 μL inserts. One 3.2 mm (˜3 μL) dried blood spot (DBS) was incubated with 200 μL precipitating agent for 30 min for extraction and subsequently diluted with 100 μL water.
LC-MS/MS
The basic high-throughput online-SPE-LC-MS/MS method was adapted regarding gradient profile and injection volume [4] . Results from those adaptions are shown in Suppl. A. In brief, a Prominence UFLC system from Shimadzu (Duisburg, Germany) was coupled to a QTRAP ® 6500 from SCIEX (Framingham, MA, USA -screen. Data acquisition using (−) MS 3 -screen is done using a broad scan width of 30 Da for the 2nd generation product ion in the ion trap to make sure not to waste sensitivity. During data procession the scan width is narrowed to 0.7 Da to eliminate interference. An overview of all methods is given in Table 1 .
Validation/verification
Between-day imprecision and accuracy were determined by 
Results
Serum cortisol analysis
In routine diagnostics of steroid hormones roughly 1% of the serum samples elicit specificity problems, almost exclusively for cortisol (> 90%). We investigated two possible ways to increase specificity without changing the basic parameters. Firstly, we made use of the susceptibility of cortisol to negative ionization and implemented it into the negative routine method for estradiol and aldosterone. Using the newly adapted (−)MS 2 -rout about half of the impaired cortisol signals could be resolved clearly (for exemplary chromatograms see Fig. 2 sample A, Fig. 3D , E, and Suppl. C outlier 1). The subsequent method verification gave between-day imprecision of 6.2% and 7.7% at 163 nmol/L and 482 nmol/L, respectively. Accuracy was 97%-98% with an LLOQ of 2.1 nmol/L. Method comparison of cortisol quantitation via (+)MS 2 -rout and the novel (−)MS 2 -rout resulted in very good correlation (R = 0.968) and method agreement (98%) (Fig. 1 ). Yet, two outliers also appeared during comparison experiments. For both samples (+)MS 2 -rout showed peak interference. Applying (−)MS 2 -rout, the cortisol peak of one sample was resolved clearly, enabling reliable quantitation, but the other remained impaired (for chromatograms see Suppl. C). This was similarly found in samples A, B, C in Fig. 3 , which also could not be cleared using negative ionization.
To overcome this limitation an extended chromatographic separation was optimized using the 100 mm Chromolith ® HR column.
Between-day imprecision and accuracy for the new (+)MS 2 -ext are given in Table 2 . DHEAS was eliminated from (+)MS 2 -ext since it did not benefit significantly from the enhanced separation and posed no issue for (+)MS 2 -rout in the first place.
A comparison of the chromatographic behavior of the modified methods is summarized in Suppl. D. Exemplary chromatograms are depicted in Suppl. E and F.
Combining both methodical modifications, we implemented a fully automatic column switching system using two 6-way valves and established a decision tree to handle problematic cases (Fig. 2-left) . In brief, impaired cortisol signals, like shown in Fig. 2 -right, can be addressed by reinjecting the sample using (−)MS 2 -rout. If this approach is unsuccessful or any other analyte is impaired, sample, calibration, and controls will be reinjected using (+)MS 2 -ext. Since cortisol makes up more than 90% of the irregularities, it is almost always (−)MS 2 -rout as first instance. Fig. 2 also shows two additional cortisol case samples from daily routine diagnostics. Sample A is clearly resolved taking the -ext) the resolution in samples B and C increased drastically (R = 1.3), while sample A appeared to be below limit of detection at that level of resolution (further exemplary chromatograms in Fig. 2 sample B) . 
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Dried blood 17-OHP analysis
In a next step the application of the regular routine method ((+) MS 2 -rout) as second tier method in CAH diagnostics from dried blood was addressed. Within-run imprecision and recovery rates are given in Table 3 . LLOQs were 0.1 nmol/L for 17-OHP, AE and 0.3 nmol/L for F in dried blood extract. This equals 3.3 nmol/L and 10 nmol/L in a 3.2 mm dried blood spot.
To investigate the potential application of the LC-MS/MS setup in primary screening as well, the gradient elution had to be optimized towards time efficiency for 17-OHP quantitation. The associated potential loss of specificity was addressed by replacing (+)MS 2 detection with (−)MS 3 . A 17-OHP chromatogram of a DBS using (−)MS 3 -screen shows two signals, one at 0.7 min and the other at 0.9 min. The first one elutes shortly after the dead time and probably contains indistinguishable matrix components and other lipids. The second one corresponds to 17OHP standard and IS (for chromatograms see Suppl. E). By narrowing the scan width during data processing, intensity for the matrix peak is reduced by 95%. LLOQ was 0.15 nmol/L in dried blood extract (5 nmol/L in a 3.2 mm dried blood spot). Imprecision and recovery are given in Table 3 .
In method comparison, 17-OHP concentrations determined by IA were on average twice as high compared to mass spectrometric methods, while about 10% were up to tenfold higher, skewing the otherwise good correlations (R((+)MS (Table 4) . Using (−)MS 3 -screen as primary screening method, 7 from 100 samples had abnormal 17-OHP results opposed to 64 samples using the immunoassay (Table 4 ).
Discussion
Routine analysis of steroid hormones requires high-throughput conditions including rapid chromatography. Hence, compromises between speed and specificity have to be made depending on the application [3, [13] [14] [15] [16] [17] [18] . Using our published method, specificity issues occurred in roughly 1% of 50,000 serum samples. More than 90% of those concerned cortisol analysis. Investigation of problematic samples revealed associations to synthetic corticoids. The patients in Fig. 3 were  treated with prednisolone (A, B, C) , budesonide (D), and spironolactone (E) amongst other drugs. These substances do not interfere directly with the cortisol measurement because of their distinguishable chromatographic behavior and precursor/product ions (see prednisolone peak in Fig. 3A-C (dashed line) ). Apparently, they rather lead to cortisol isomers through metabolization or affect its metabolism [19] [20] [21] [22] . Kushnir et al. encountered this case for prednisolone, described tetrahydroprednisolone as the interfering metabolite, and solved the issue using their cortisol qualifier mass transition (m/z 363 > 97), which was unaffected, instead of the quantifier (m/z 363 > 121) for quantitation [23] . The qualifier we use (m/z 363 > 81) is affected, though. Since this metabolite might be our encountered interference as well, implementing m/z 363 > 97 in.(+)MS 2 -rout, could be another option to solve specificity problems regarding prednisolone medication. Technically, however, tetrahydroprednisolone should produce a precursor at m/z 365 and therefore should be distinguishable from cortisol. The prednisone metabolite tetrahydroprednisone on the other hand ionizes as m/z 363 like cortisol and should be considered as potential interference [20] . Budesonide and spironolactone, though readily quantifiable via LC-MS/MS [24, 25] , have not yet been further investigated regarding potential interference in cortisol quantitation by their metabolites. Explicit experiments concerning potentially interfering pharmaceuticals are being planned and will be conducted going forward. Interference due to pathology has to be considered as well. For example, in Cushing's syndrome an increase of the cortisol isomers 20α-and 20β-dihydrocortisone can lead to an elevated cortisol signal, if not sufficiently separated, since they share the same mass transitions [26] .
Addressing specificity problems by switching to negative ionization for cortisol analysis showed an improvement of analytical specificity in roughly 50% of the problematic cases. Cortisol as well as 17-OHP, although routinely measured using (+)MS 2 , are susceptible to negative ionization, which is known to be less prone to matrix effects like ion suppression [27, 28] . Furthermore, fragmentation under negative ionization follows different mechanisms and avoids common steroid fragments like m/z 79, 97, 109, 121 which appear ubiquitously in positive ionization. However, due to their chemical properties the analytes at hand are more susceptible to positive ionization in general. Hence, sensitivity has to be sacrificed in favor of specificity. As a second way to address specificity issues we provide the extension of the chromatography for improved separation from coeluting interferences. Using Lvl 2  18  9  83  14  3  79  442  3  102  21  7  101  Lvl 3  44  7  103  22  6  80  496  6  105  41  9  97  Lvl 4  71  9  84  37  12  75  575  7  92  68  11  80  Lvl 5  157  7  93  67  2  73  782  1  98  156  6  92 a within-run imprecision n = 3. -ext remaining problematic cases could be resolved apart from samples with very low cortisol concentrations due to suppression by medication (Fig. 3-A , approximately below 1 nmol/L). Except for DHEAS, the residual analytes of (+)MS 2 -rout stayed included in the extended method, since specificity issues concerning them, although ten times more uncommon than for cortisol, can still occur. A chromatographic extension for (−)MS 2 -rout was not implemented because specificity problems for aldosterone and estradiol did not occur during routine analysis. With these two approaches, that we build the decision tree on, we make use of the orthogonal nature of specificity provided by RP-HPLC and mass spectrometry. When an unclear cortisol result occurs, we use (−)MS 2 -rout as first instance instead of extended chromatography despite lower sensitivity. The reason is that calibration and control samples are measured first on any given day using (+/−)MS 2 -rout. So, the unclear cortisol sample can be reinjected and processed immediately using the calibration at hand, while using (+)MS 2 -ext also demands reinjecting calibration and control samples. The time advantage is evident and opting for (+)MS 2 -ext is still possible afterwards. Our second main consideration concerned dried blood 17-OHP analysis in context of CAH diagnostics. The use of immunometric assays as primary screening is lawfully regulated [Kinder-Richtline §17(2), Gemeinsamer Bundasausschuss]. These assays often suffer from falsely elevated concentrations due to EDTA contamination or cross reactivity [29, 30] . Furthermore, increased 17-OHP levels due to an upregulated steroid metabolism can lead to false positive screening results as well, since elevated corticoid levels are not being taken into account. To address such circumstances, 2nd tier analysis using LC-MS/MS has been well established [12, 17, [31] [32] [33] [34] . Hereby, the quantitation of steroid profiles rather than single analytes allows the use of concentration ratios for clinical assessment of results, increasing diagnostic specificity drastically [12, 35] . We showed that our high-throughput LC-MS/MS method can directly be used for 2nd tier dried blood analysis, with minimal change in sample preparation, due to recovery rates between 80% and 100% in clinically relevant decision ranges. However, a major limitation of this application derived from its development under the premise of maximum conservation of established routine analysis conditions -meaning the use of chemicals, solutions, and procedures. Our DBS sample pretreatment, therefore, leads to a dilution factor of 100 resulting in high LLOQs. Established procedures produce factors roughly between 3 and 16, allowing for better sensitivity [15, 17, 31, 34, 36, 37] . The low recovery rate of 64% for 17-OHP at the lowest spike level appears to be the result of the high dilution factor (Table 3) . Since this method is applied for confirmation of abnormally high values, however, the drawback is negligible. Yet, the use of more than one DBS per analysis might be an option to improve LLOQs in the future. (+)MS 2 -rout also qualifies for 17-OHP quantitation in primary screening in general, but, with a total run time of 4.3 min, would be too slow for screening purposes. The chromatographic separation would have to be accelerated massively, reducing specificity of 17-OHP MS screen, with a run time of 1.5 min, sacrificed for the benefit of analysis time. This loss can be balanced by utilizing the ion trap and adding a second fragmentation step via resonance excitation, providing the specificity needed to reliably quantitate 17-OHP from dried blood spots on a screening time scale. Recovery rates (80-103%, Table 3 ) support this claim and the good recovery at the lowest spike level even suggests that (−)MS 3 -screen is more specific in low concentration ranges than (+)MS 2 -rout, although being slightly less sensitive. In conclusion, the methodical approach of using LC-MS 3 for primary CAH screening is viable and will be tested in a pilot study where parallel measurements to the regular CAH screening will be conducted to prove its stability compared to IA. For an actual use as primary screening method, however, certified calibration and control material needs to be developed. Further restraints are that LC-MS/MS is not yet fully automated, especially the use of an ion trap requiring special training and knowledge, and that, due to the longer time MS 3 experiments take compared to MS 2 , implementing more than one analyte and IS into a single method is not recommend. Although it would technically be possible, the negative effect on cycle time and therefore data points per peak would increase imprecision drastically, given the very narrow peaks in modern HPLC based methods.
Regarding comparison of the CAH screening methods, both IA and (−)MS 3 -screen were able to recognize the three cases of 21-hydroxylase deficiency. Yet, a total of 64 positive results using IA require laborious follow-up analysis. This can be avoided applying the LC-MS 3 approach to CAH screening reducing the need of follow-up experiments by 90%. We therefore claim that the substitution of LC-MS 3 for IA in primary CAH screening is highly beneficial. Especially considering that follow-up second tier analysis via LC-MS/MS can be done directly from the processed sample used in the screening process.
To conclude, the general LC-MS/MS setup at hand has proven its high robustness over the past 3 years in high-throughput routine analysis as well as clinical trials concerning steroid hormones in serum, saliva, and hair [5] [6] [7] [8] [9] . For the latter MS 3 quantitation was applied as
well. This underlines a great advantage of LC-MS/MS in general as its immense flexibility cannot be stressed enough. Regarding our particular method switching strategy, routine diagnostics of our steroid hormone panel as well as several other applications concerning steroid analysis in different biologic matrices can be run in succession without having to change components or mobile phases at all. The combined pool of the original methods and the presented optimizations yields a toolbox system capable of switching from serum estradiol to hair cortisol to dried blood 17-OHP by a single mouse click.
Conclusion
We provide results from analytical problems we encountered in the past 3 years of routine diagnostics of steroid hormones and present a decision tree to help navigate such encounters in the future. Hereby, being able to vary chromatography and ionization without any methodical hands-on changes accelerates problem solving on a daily routine work level. Furthermore, utilizing MS 3 detection combined with a very short chromatography is a potential way to keep up with the speed of CAH screening via fully automated immunoassays, while completely outperforming them regarding specificity and need for follow-up analysis.
